Palisade Bio, Inc. (PALI) stock
PALINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$0.94−0.07 (-6.72%)
Close on Nov 18, 2026Market cap $164.18MP/E –Yield –
Palisade Bio price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Palisade Bio's price to sales ratio was 406.2× on Nov 11, 2026, against 41.3× a year earlier. Over the last 3 years it ranged from 14.8× to 468.7×, with a median of 90.0×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 406.2× | +391.3 |
| 2024 | Apr 30, 2024 | 14.9× | −6.8 |
| 2023 | Dec 29, 2023 | 21.7× | −24.5 |
| 2019 | Jul 31, 2019 | 46.2× | −9.8 |
| 2018 | Dec 31, 2018 | 56.0× | −410.7 |
| 2012 | Oct 31, 2012 | 466.7× | – |
See a number that looks wrong?